Nicolas Blondiaux
Overview
Explore the profile of Nicolas Blondiaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caulier T, Senneville E, Sobocinski J, Leroy O, Patoz P, Blondiaux N, et al.
Infection
. 2024 Feb;
52(3):1153-1158.
PMID: 38329687
Purpose: We aimed to assess risk factors of candida-related Vascular Graft Infections (VGIs). Methods: We did a case-control study (1:4) matched by age and year of infection, nested in a...
2.
Boucher A, Pradier M, Lafondesmurs B, Thill P, Patoz P, Blondiaux N, et al.
Infect Dis Now
. 2023 Nov;
54(1):104835.
PMID: 37972818
Objectives: We aimed to describe the efficacy and safety of dalbavancin in treatment of patients with diabetes-related foot osteomyelitis with bone culture confirmation. Patients And Methods: Between January 2019 and...
3.
Senneville E, Gachet B, Blondiaux N, Robineau O
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830229
The choice of antibiotic regimens for use in patients presenting with diabetic foot osteomyelitis and their duration differs according to the situation. Antibiotics play a more important role in the...
4.
Thill P, Robineau O, Roosen G, Patoz P, Gachet B, Lafon-Desmurs B, et al.
J Antimicrob Chemother
. 2022 Jan;
77(4):1036-1040.
PMID: 35028671
Background: Staphylococci account for approximately 60% of periprosthetic joint infections (PJIs). Rifampicin (RMP) combination therapy is generally considered to be the treatment of choice for staphylococcal PJIs but carries an...
5.
Coehlo A, Robineau O, Titecat M, Blondiaux N, Dezeque H, Patoz P, et al.
J Antimicrob Chemother
. 2021 Aug;
76(11):3033-3036.
PMID: 34406411
Background: The optimal length of the intravenous antibiotic treatment of periprosthetic joint infections (PJIs) generally ranges from one to six weeks and is a matter of debate. Most antibiotics active...
6.
Meybeck A, Tetart M, Baclet V, Alcaraz I, Blondiaux N, Peytavin G, et al.
Int J Infect Dis
. 2021 Apr;
107:176-178.
PMID: 33872782
Background: Disseminated Mycobacterium marinum infections occur rarely, in immunocompromised patients. Treatment with a prolonged multi-drug regimen exposes patients to drug-drug interactions and side effects. Case Report: We report a case...
7.
Senneville E, Dinh A, Ferry T, Beltrand E, Blondiaux N, Robineau O
Antibiotics (Basel)
. 2020 Dec;
10(1).
PMID: 33374817
Objectives: Data on clinical and biological tolerance of tedizolid (TZD) prolonged therapy are lacking. Methods: We conducted a prospective multicentre study including patients with prosthetic joint infections (PJIs) who were...
8.
Senneville E, Joulie D, Blondiaux N, Robineau O
J Bone Jt Infect
. 2020 Jul;
5(4):198-204.
PMID: 32670774
Surgery is an important part of the management of patients diagnosed with DFO. It consists in some selected patients, to remove all or part of the infected bone(s) or even...
9.
Berthol N, Robineau O, Boucher A, Blondiaux N, Beltrand E, Valette M, et al.
Diabetes Care
. 2017 Oct;
40(12):e170-e171.
PMID: 28993420
No abstract available.
10.
Blondiaux N, Moune M, Desroses M, Frita R, Flipo M, Mathys V, et al.
Science
. 2017 Mar;
355(6330):1206-1211.
PMID: 28302858
Antibiotic resistance is one of the biggest threats to human health globally. Alarmingly, multidrug-resistant and extensively drug-resistant have now spread worldwide. Some key antituberculosis antibiotics are prodrugs, for which resistance...